All News

AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

May 5th 2025, 4:00pm

Article

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.

First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers

May 5th 2025, 3:00pm

Article

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.

Cancer Survivor Raises AYA Awareness After Rare Lymphoma Diagnosis

May 5th 2025, 1:00pm

Article

In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support for young adults with cancer.

POIESIS Trial Explores Navtemadlin Plus Jakafi for Myelofibrosis

May 5th 2025, 12:00pm

Article

The phase 3 POIESIS trial is set to investigate navtemadlin as an add-on therapy to Jakafi in patients with JAK inhibitor-naive myelofibrosis.

An Expert Offers Advice and Resources for Navigating Rare Lymphoma

May 4th 2025, 6:00pm

Article

Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face.

Celebrating an Expert at Emotional Support

May 4th 2025, 2:00pm

Article

It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology Nursing.

Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC

May 3rd 2025, 6:00pm

Video

Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer.

A Healer’s Touch During My Experience With Cancer Care

May 3rd 2025, 2:00pm

Article

The Calm of Unbroken Kindness

May 2nd 2025, 9:00pm

Article

The nursing profession is home to countless extraordinary.

Breaking Down the Benefits of Clinical Trial Participation in Cancer Care

May 2nd 2025, 8:00pm

Video

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.